Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2003
11/27/2003US20030220494 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220389 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220385 Nitrogen compounds such as 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)-6-fluoroindazole, administered as phosphodiesterases inhibitors for prophylaxis of cardiovascular or sexual disorders, or as hypotensive agents
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220367 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
11/27/2003US20030220349 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003US20030220330 Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
11/27/2003US20030220325 Such as 1-(4-(phenylsulfonyl)-naphthyl)piperazine; for treating treating diseases related to 5-HT receptor; radiolabelling
11/27/2003US20030220319 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders
11/27/2003US20030220292 Treatment of erectile dysfunction
11/27/2003US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments.
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219499 Therapy of estrogen-associated disorders
11/27/2003US20030219471 Administering to a menstruating female a cycle of contraceptive therapy, including, for at least 42 successive days, the administration of a combination of an estrogen and a progestogen as contraceptive daily dosage
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003CA2486124A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
11/27/2003CA2485081A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2483770A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003CA2483619A1 Novel compounds and their use
11/26/2003EP1364963A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364950A1 Pyridopyrimidine or naphthyridine derivative
11/26/2003EP1364658A1 Use of varying ratios of gonadotrophins in controlled ovarian hyperstimulation
11/26/2003EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
11/26/2003EP1363944A2 High-affinity antagonists of elr-cxc chemokines
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
11/26/2003EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
11/26/2003EP1363909A2 Tricyclic androgen receptor modulator compounds
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363669A2 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea
11/26/2003EP1363641A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363628A2 Drugs for sex dysfunctions
11/26/2003EP1363608A1 Treatment of sleep disturbances
11/26/2003EP1259523B1 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP0927177B1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
11/26/2003EP0888123B1 Antagonism of endothelin actions
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1457856A Compound toxin-eliminating bolus
11/26/2003CN1457855A Yin-toxin source eliminating pill
11/26/2003CN1457848A Black-bone chicken white phoenix preparation medicine and its preparing method
11/26/2003CN1457835A Draqon's blood dripping pill for removing blood stasis and killing pain, arresting bleeding and promoting granulation and its preparing method
11/26/2003CN1457823A Amomum fruit oil soft capsule
11/26/2003CN1457799A Compound composition for curing male's sterility
11/26/2003CN1128633C Exterior-applied medicine for treating gynopathy
11/25/2003USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/25/2003US6653460 Voltage-gated calcium channel antagonist and method
11/25/2003US6653347 For therapy
11/25/2003US6653338 FSH mimetics for the treatment of infertility
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653286 Gonadotropin releasing hormone antagonist
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/20/2003WO2003095644A1 Novel proteins and dnas thereof
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095428A1 Dopamine receptor modulators as antipsychotic agents
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003WO2003094944A1 Formulations useful in the treatment of male and female impotence
11/20/2003WO2003094943A1 Formulations useful in the treatment of male and female impotence
11/20/2003WO2003094920A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003016331A3 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
11/20/2003WO2003014079A8 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003004613A3 Novel pgc-1 isoforms and uses therefor
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002083736A3 G-protein coupled receptor molecules and uses thereof
11/20/2003WO2002069906A3 Compounds and methods for the treatment of urogenital disorders
11/20/2003WO2002038744A3 Proteases
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216413 Catecholamine pharmaceutical compositions and methods
11/20/2003US20030216408 -4-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl)-piperazin -1-yl)propy l)-N-pyridin-2-yl-benzamide or salt; useful as 5-HT1A receptor antagonists
1 ... 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 ... 557